Pfizer (PFE) Dividends Paid - Common (2009 - 2026)

Pfizer has disclosed Dividends Paid - Common across 18 years of filings, most recently posting $2.4 billion for Q1 2026.

• In Q1 2026, Dividends Paid - Common changed 0.33% year-over-year to $2.4 billion; the TTM figure through Mar 2026 stood at $9.8 billion (down 31.72% YoY), while the FY2025 annual figure was $9.8 billion, up 2.72% from the prior year.
• Dividends Paid - Common held at $2.4 billion in Q1 2026, from $2.4 billion in the prior quarter.
• Over the last five years, Dividends Paid - Common for PFE reached as high as $7.1 billion in Q3 2024 and fell as low as $2.2 billion in Q3 2022.
• The 5-year median for Dividends Paid - Common is $2.4 billion (2024), against an average of $3.0 billion.
• Annual changes were most pronounced in 2024 — Dividends Paid - Common jumped 208.21% — and 2025, when it tumbled 65.73%.
• A 5-year view of Dividends Paid - Common shows it stood at $6.7 billion in 2022, then sank by 65.64% to $2.3 billion in 2023, then surged by 208.08% to $7.1 billion in 2024, then slumped by 65.72% to $2.4 billion in 2025, then changed by 0.0% to $2.4 billion in 2026.
• According to Business Quant data, Dividends Paid - Common over the past three periods registered $2.4 billion, $2.4 billion, and $2.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.